Norway vs Switzerland: Proportion of bloodstream infection due to methicillin-resistant
Norway
2.1%
in 2023
Switzerland
4.0%
in 2023
Norway rank
53rd
Switzerland rank
50th
Proportion of bloodstream infection due to methicillin-resistant over time
- Norway
- Switzerland
How they compare
Switzerland currently reports 4.0% against 2.1% in Norway, a difference of 1.9%.
That makes Switzerland's figure about 1.9 times Norway's.
Across all 7 years both countries report, Switzerland has been ahead every year.
Norway ranks 53rd and Switzerland ranks 50th of 55 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.1% | 4.8% | 3.8% | Switzerland |
| 2020s | 1.7% | 4.5% | 2.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Norway or Switzerland?
- Switzerland, at 4.0% against 2.1% in Norway as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Norway and Switzerland?
- 1.9%, with Switzerland ahead.
- How many years of comparable data are there for Norway and Switzerland?
- 7 years are reported by both, from 2016 to 2023.
- How do Norway and Switzerland rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Norway ranks 53rd and Switzerland ranks 50th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.